Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 13/20 | 0.45 |
| ▸ | CD274 | Q9NZQ7 | 4/20 | 0.43 |
| ▸ | PLA2G7 | Q13093 | 4/20 | 0.43 |
| ▸ | ABHD6 | Q9BV23 | 4/20 | 0.43 |
| ▸ | PDCD1LG2 | Q9BQ51 | 3/20 | 0.43 |
| ▸ | CCR2 | P41597 | 1/20 | 0.41 |
| ▸ | CNR2 | P34972 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19628004 | 1.00 | MGLL (0.45) | MGLLCD274PLA2G7ABHD6PDCD1LG2 | |
| SCHEMBL18087098 | 0.92 | MGLL (0.54) | MGLLPLA2G7ABHD6 | |
| SCHEMBL18087097 | 0.92 | MGLL (0.54) | MGLLPLA2G7ABHD6 | |
| SCHEMBL18064803 | 0.87 | MGLL (0.56) | MGLLPLA2G7ABHD6 | |
| SCHEMBL19628003 | 0.86 | MGLL (0.51) | MGLLPLA2G7ABHD6 | |
| SCHEMBL19627999 | 0.84 | MGLL (0.52) | MGLLPLA2G7ABHD6 | |
| SCHEMBL19628024 | 0.83 | MGLL (0.57) | MGLLPLA2G7ABHD6 | |
| SCHEMBL18064749 | 0.82 | CD274 (0.50) | CD274PDCD1LG2CCR2 | |
| SCHEMBL18064750 | 0.82 | CD274 (0.50) | CD274PDCD1LG2CCR2 | |
| SCHEMBL18064840 | 0.82 | CD274 (0.50) | CD274PDCD1LG2CCR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170334874-A1 | PIPERAZINE CARBAMATES AND METHODS OF MAKING AND USING SAME | H. LUNDBECK A/S (DK) | 2017-11-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170334874-A1 | PIPERAZINE CARBAMATES AND METHODS OF MAKING AND USING SAME | ABHD6, RABL6, ABHD16A | MGLL 46/4885CD274 4799/4885PLA2G7 204/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.